Literature DB >> 33505217

The Relationship between Retinol-Binding Protein 4 and Markers of Inflammation and Thrombogenesis in Children with Kawasaki Disease.

Maoling Yang1,2, Haobo Weng1,2, Qiongfei Pei1,2, Fengchuan Jing1,2, Qijian Yi1.   

Abstract

BACKGROUND: Kawasaki disease (KD) is a self-limited vasculitis with unknown etiologies, and coronary artery lesions (CALs) are the most common and serious complications. Retinol-binding protein 4 (RBP4) has been confirmed effects on vasodilation, platelet activation inhibition, and cardiovascular diseases by researches. Therefore, this study was aimed at investigating the relationship between RBP4 and inflammation as well as thrombogenesis in children with KD.
METHODS: 79 subjects were from 62 children with KD and 17 healthy controls (HCs). The KD group was divided into KD with CALs (KD-CALs) and KD without CALs (KD-NCALs), and the serum RBP4 levels were measured by enzyme-linked immunosorbent assay (ELISA).
RESULTS: Compared with the HC group, serum RBP4 levels in the KD group were significantly decreased (p < 0.05). RBP4, hemoglobin (Hb), and mean platelet volume (MPV) levels were higher, while platelet counts (Plt) and thrombin time (TT) levels were lower in the KD-NCALs group than in the KD-CALs group (p < 0.05). RBP4 had positive correlation with time point of intravenous immunoglobulin (IVIG), Hb, and percentage of leukomonocytes (L%) and negative correlation with the percentage of neutrophils (N%), MPV, C-reactive protein (CRP), neutrophil-to-lymphocyte ratio (NLR), prothrombin time (PT), fibrinogen (Fbg), and D-dimer (DD) in the KD group; RBP4 had positive correlation with the time point of IVIG and L% and negative correlation with N%, MPV, and NLR in the KD-NCALs group; and RBP4 had positive correlation with Hb and L% and negative correlation with N%, CRP, NLR, and PT in the KD-CALs group (p < 0.05). Multiple linear regression analysis confirmed that Hb and CRP in the KD group, MPV and N% in the KD-NCALs group, and PT and CRP in the KD-CALs group were independent predictors of RBP4 (p < 0.05).
CONCLUSION: Lower RBP4 was observed in the KD group than in the HC group, and RBP4 had associations with markers of inflammation and thrombogenesis in children with KD.
Copyright © 2021 Maoling Yang et al.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33505217      PMCID: PMC7814943          DOI: 10.1155/2021/7029514

Source DB:  PubMed          Journal:  Mediators Inflamm        ISSN: 0962-9351            Impact factor:   4.529


  34 in total

1.  Relationship between mean platelet volume-to-lymphocyte ratio and coronary artery abnormalities in Kawasaki disease.

Authors:  Gulcin Bozlu; Derya Karpuz; Olgu Hallioglu; Selma Unal; Necdet Kuyucu
Journal:  Cardiol Young       Date:  2018-04-16       Impact factor: 1.093

2.  Guidelines for diagnosis and management of cardiovascular sequelae in Kawasaki disease (JCS 2013). Digest version.

Authors: 
Journal:  Circ J       Date:  2014-09-22       Impact factor: 2.993

3.  Retinol-binding protein 4 as a novel risk factor for cardiovascular disease in patients with coronary artery disease and hyperinsulinemia.

Authors:  Fei Li; Ke Xia; Chuanchang Li; Tianlun Yang
Journal:  Am J Med Sci       Date:  2014-12       Impact factor: 2.378

4.  Lipid-rich plaque in possible coronary sequelae of Kawasaki disease detected by optical frequency domain imaging.

Authors:  Jun Shiraishi; Masaki Yashige; Masayuki Hyogo; Takatomo Shima; Takahisa Sawada; Yoshio Kohno
Journal:  Cardiovasc Interv Ther       Date:  2014-10-29

5.  Retinol-binding protein 4 levels and susceptibility to ischaemic events in men.

Authors:  Judit Cubedo; Teresa Padró; Juan Cinca; Pedro Mata; Rodrigo Alonso; Lina Badimon
Journal:  Eur J Clin Invest       Date:  2014-01-11       Impact factor: 4.686

Review 6.  Retinol binding protein 4 in relation to diet, inflammation, immunity, and cardiovascular diseases.

Authors:  Fateme Zabetian-Targhi; Mohammad J Mahmoudi; Nima Rezaei; Maryam Mahmoudi
Journal:  Adv Nutr       Date:  2015-11-13       Impact factor: 8.701

7.  Increased RBP4 in a human model of activated anti-atherosclerotic and antiremodelling defences.

Authors:  Lorenzo A Calò; Giuseppe Maiolino; Elisa Pagnin; Ugo Vertolli; Paul A Davis
Journal:  Eur J Clin Invest       Date:  2014-06       Impact factor: 4.686

8.  The role of retinol-binding protein 4 and its relationship with sex hormones in coronary artery disease.

Authors:  Hongxia Wang; Ping Zhou; Dan Zou; Ying Liu; Xiang Lu; Zhengxia Liu
Journal:  Biochem Biophys Res Commun       Date:  2018-10-17       Impact factor: 3.575

9.  The relationship between circulating irisin, retinol binding protein-4, adiponectin and inflammatory mediators in patients with metabolic syndrome.

Authors:  Omur Tabak; Gonul Simsek; Fusun Erdenen; Volkan Sozer; Tuna Hasoglu; Remise Gelisgen; Esma Altunoglu; Cuneyt Muderrisoglu; Abdulhalim Senyigit; Hafize Uzun
Journal:  Arch Endocrinol Metab       Date:  2017-09-18       Impact factor: 2.309

10.  Hypercoagulation and elevation of blood triglycerides are characteristics of Kawasaki disease.

Authors:  Xi Chen; Zhen-Wen Zhao; Lin Li; Xue-Jun Chen; Hui Xu; Jin-Tu Lou; Lin-Jie Li; Li-Zhong Du; Chun-Hong Xie
Journal:  Lipids Health Dis       Date:  2015-12-30       Impact factor: 3.876

View more
  3 in total

1.  Leukocytic dysregulation in children with type 1 diabetes: relation to diabetic vascular complications.

Authors:  Nouran Yousef Salah; Nesrine Radwan; Heba Mohamed Atif
Journal:  Diabetol Int       Date:  2022-01-07

Review 2.  Thromboinflammatory Processes at the Nexus of Metabolic Dysfunction and Prostate Cancer: The Emerging Role of Periprostatic Adipose Tissue.

Authors:  Ibrahim AlZaim; Aya Al-Saidi; Safaa H Hammoud; Nadine Darwiche; Yusra Al-Dhaheri; Ali H Eid; Ahmed F El-Yazbi
Journal:  Cancers (Basel)       Date:  2022-03-25       Impact factor: 6.639

Review 3.  Neutrophil to Lymphocyte Ratio as a Biomarker for Predicting the Coronary Artery Abnormality in Kawasaki Disease: A Meta-Analysis.

Authors:  Shirin Sarejloo; Matin Moallem Shahri; Pouria Azami; Alec Clark; Ethan Hass; Maryam Salimi; Brandon Lucke-Wold; Shahram Sadeghvand; Shokoufeh Khanzadeh
Journal:  Dis Markers       Date:  2022-10-11       Impact factor: 3.464

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.